NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
EVFM Evofem Biosciences
- 0.009
- 0.000-3.69%
15min DelayClose Dec 20 16:00 ET
943.09KMarket Cap0.00P/E (TTM)
0.010High0.009Low841.74KVolume0.010Open0.010Pre Close7.66KTurnover0.84%Turnover Ratio0.19P/E (Static)100.33MShares0.07552wk High-0.01P/B943.06KFloat Cap0.00652wk Low--Dividend TTM100.33MShs Float23550.000Historical High--Div YieldTTM12.30%Amplitude0.006Historical Low0.009Avg Price1Lot Size
Evofem Biosciences Key Stats
EPS
According to the latest financial report of Evofem Biosciences, the latest earnings per share (TTM) for the company is -0.02. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Evofem Biosciences's free cash flow? The latest report shows it as -459.00K. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Evofem Biosciences shows that the company's current ratio is 0.11, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Evofem Biosciences, the quick ratio is 0.07, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Evofem Biosciences? The latest ROE figure is -195.38%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Evofem Biosciences, the total asset return on investment (ROA) is -14.59%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Evofem Biosciences's latest financial report to see how their gross margin is doing - currently at 80.67%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Evofem Biosciences, the net profit margin is -52.60%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.